ASSOCIATIONS BETWEEN MOLECULAR SUBTYPES AND POSTOPERATIVE COMPLICATIONS AFTER PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED STAGE HIGH-GRADE SEROUS OVARIAN CANCER

被引：0
|
作者：
Torres, D. [1 ]
Kumar, A. [1 ]
Bakkum-Gamez, J. [1 ]
Langstraat, C. [1 ]
Goode, E. [2 ]
Cliby, W. [1 ]
Wang, C. [2 ]
机构：
[1] Mayo Clin, Gynecol Surg, Rochester, MN USA
[2] Mayo Clin, Hlth Sci Res, Rochester, MN USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0806
引用
收藏
页码：1693 / 1693
页数：1
相关论文
共 50 条
  • [41] NKG2D-mediated cytotoxicity improves after primary surgery for high-grade serous ovarian cancer
    Israelsson, Pernilla
    Bjork, Emma
    Nagaev, Ivan
    Nagaeva, Olga
    Lundin, Eva
    Mincheva-Nilsson, Lucia
    Ottander, Ulrika
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 89 (01)
  • [42] Validation of the MAL gene as a predictor of survival in advanced-stage high-grade serous ovarian cancer
    Barnett, J. C.
    Iverson, E.
    Dressman, H.
    Whitaker, R.
    Murphy, S. K.
    Lancaster, J.
    Berchuck, A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S123 - S124
  • [43] Efficient molecular subtype classification of high-grade serous ovarian cancer
    Leong, Huei San
    Galletta, Laura
    Etemadmoghadam, Dariush
    George, Joshy
    Koebel, Martin
    Ramus, Susan J.
    Bowtell, David
    JOURNAL OF PATHOLOGY, 2015, 236 (03): : 272 - 277
  • [44] Investigating the impact of interval from primary debulking surgery to initiation of adjuvant chemotherapy in advanced high-grade serous ovarian cancer
    Lee, Y.
    Lu, L.
    Xu, W.
    Brown, T.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 185 - 185
  • [45] Reading the signs: Radiographic characterization of morphologic subtypes of high-grade serous ovarian cancer
    Foster, Katherine
    Handley, Katelyn
    Bhosale, Priya
    Glassman, Deanna
    Sims, Travis
    Javadi, Sanaz
    Palmquist, Sarah
    Saleh, Mohammed
    Fellman, Bryan
    Fleming, Nicole
    Sood, Anil
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S87 - S88
  • [46] Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer
    Tucker, Susan L.
    Gharpure, Kshipra
    Herbrich, Shelley M.
    Unruh, Anna K.
    Nick, Alpa M.
    Crane, Erin K.
    Coleman, Robert L.
    Guenthoer, Jamie
    Dalton, Heather J.
    Wu, Sherry Y.
    Rupaimoole, Rajesha
    Lopez-Berestein, Gabriel
    Ozpolat, Bulent
    Ivan, Cristina
    Hu, Wei
    Baggerly, Keith A.
    Sood, Anil K.
    CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3280 - 3288
  • [47] Ultrasound characteristics of early-stage high-grade serous ovarian cancer
    Suh-Burgmann, Elizabeth
    Brasic, Natasha
    Jha, Priyanka
    Hung, Yun-Yi
    Goldstein, Ruth B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (04) : 409.e1 - 409.e8
  • [48] Lipid Alterations in Early-Stage High-Grade Serous Ovarian Cancer
    Iurova, M. V.
    Chagovets, V. V.
    Pavlovich, S. V.
    Starodubtseva, N. L.
    Khabas, G. N.
    Chingin, K. S.
    Tokareva, A. O.
    Sukhikh, G. T.
    Frankevich, V. E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [49] First-Line Management of Advanced High-Grade Serous Ovarian Cancer
    Mahmood, Reem D.
    Morgan, Robert D.
    Edmondson, Richard J.
    Clamp, Andrew R.
    Jayson, Gordon C.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (06)
  • [50] Use of frontline maintenance treatment following cytoreductive surgery in advanced high-grade serous ovarian cancer: a memorial Sloan Kettering team ovary study
    Finch, Lindsey
    Finlan, Michael
    Broach, Vance
    Chi, Dennis
    Roche, Kara Long
    Gardner, Ginger
    Al-Niaimi, Ahmed
    O'cearbhaill, Roisin
    Grisham, Rachel
    Abu-Rustum, Nadeem
    Sonoda, Yukio
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A215 - A215
12345